<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A case of peripheral <z:hpo ids='HP_0100758'>gangrene</z:hpo> and <z:hpo ids='HP_0000083'>renal failure</z:hpo> following the use of dihydroergotamine (DHE) for treatment of <z:e sem="disease" ids="C0151740" disease_type="Disease or Syndrome" abbrv="">raised intracranial pressure</z:e> (ICP) is reported </plain></SENT>
<SENT sid="1" pm="."><plain>There have been several reports of vasospasm and peripheral <z:hpo ids='HP_0100758'>gangrene</z:hpo> caused by DHE used in combination with <z:chebi fb="5" ids="28304">heparin</z:chebi> for prevention of <z:hpo ids='HP_0002625'>deep venous thrombosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Clinical experience with the use of DHE in head trauma is limited </plain></SENT>
<SENT sid="3" pm="."><plain>This case report emphasises the seriousness of the adverse effects associated with the use of this drug </plain></SENT>
</text></document>